XCell Biosciences - Cell culturing technology to enhance drug screening and the performance of cell therapies episode artwork

EPISODE · Sep 14, 2021 · 1H 19M

XCell Biosciences - Cell culturing technology to enhance drug screening and the performance of cell therapies

from Lab to Startup

In this episode of Lab to Startup, I speak with Brian Feth and James Lim, co-founders of XCellBio. We explore the startup story and learn about: The founding story- the initial hypothesis behind the product they wanted to build and how the technology evolved since then based on customer feedback Fundraising trials and tribulations How there was a lesson hidden in every "No" they received from potential customers and investors Role that partnerships played Traits like flexibility, open communication and co-founder chemistry Learn more about XCell Biosciences: https://www.xcellbio.com

Episode metadata supplied by the publisher feed · Published Sep 14, 2021

Embed this episode

NOW PLAYING

XCell Biosciences - Cell culturing technology to enhance drug screening and the performance of cell therapies

0:00 1:19:05

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Lab to Startup?

This episode is 1 hour and 19 minutes long.

When was this Lab to Startup episode published?

This episode was published on September 14, 2021.

Can I download this Lab to Startup episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!